The goal in this study was to clarify the color-change mechanisms of methyl orange (MO) bound to human serum albumin (HSA) and the structure of the binding site. The absorbance of the MO-HSA complex was measured at 560 nm in solutions of varying pH (pH 2.4-6.6). The obtained pHdependent experimental data were consistent with the data calculated using the HendersonHasselbalch equation and pKa values (3.8, MO; 1.4, carboxyl group). The extent of the binding of MO to an HSA molecule was determined to be 1-4 by performing surface plasmon resonance analysis. Furthermore, the binding of MO to HSA was inhibited by warfarin. A fitting model of MO to HSA was created to evaluate these results based on PDB data (warfarin-HSA complex: 2BXD) and protein-structure analysis. The color-change mechanism of the MO-HSA complex appears to be as follows: the dissociated sulfo group of MO binds to Arg218/Lys444 sidechains through electrostatic interaction in the warfarin-binding site, and, subsequently, the color change occurs through a proton exchange between the diazenyl group and the γ-carboxyl group of Glu292. The color-changed MO is fixed in the warfarin-binding site. These results could support the development of a reliable dye-binding method and of a new method for staining diverse tissues that is based on a validated mechanism.
Metachromasy is the characteristic color change of an acidic or basic dye used for staining biological tissues or cells (1, 7) . The mechanism underlying metachromasy is considered to involve hydrophobic and hydrophilic interactions between basic (cationic) dyes, such as toluidine blue and methylene blue, and polyanions, such as nucleic acids and mucopolysaccharides containing phosphate and sulfate groups, respectively, and the resulting color change occurs through dye aggregation. In the case of acidic (anionic) dyes, the dyes interact with the amino groups of proteins (14, 16) . Many pH indicators such as bromocresol green (BCG), bromocresol purple (BCP), and phenolphthalein exhibit metachromasy, and when albumin, which can adsorb various organic compounds (2) , is added to a pH indicator in a buffered solution, the resulting color change in the indicator is equivalent to that which occurs in a solution of high or low pH. In clinical environments, dye-binding methods involving the use of BCG and BCP that are employed for quantifying human serum albumin (HSA) are based on this property of albumin (3) . Because the color change occurs in a buffered solution whose pH is constant, a proton-exchange reaction occurs between the molecules. In the case of pH indicators, the amount of pH-dependent color change is measured using a photometric method after the binding of the indicator to HSA, and the amount is calculated using the Henderson-Hasselbalch equation. In our previous work, a comparison between experimental and calculated pH-dependent data indicated that color change tion and pKa 1 (MO) and pKa 2 (carboxyl group).
Determination of the number of MOs that bind on HSA. Surface plasmon resonance (SPR) analyses were performed using a BIACORE 2000 system equipped with a CM5 sensor chip (GE Healthcare Japan, Tokyo). Fatty acid-free HSA was immobilized on the chip by using a standard protocol involving amine-coupling chemistry (GE Healthcare, kit BR-1000-50). All operations were performed in a working buffer containing 1% DMSO at 25°C. MO was injected over the HSA and the reference surface at concentrations ranging from 40 to 2.5 μmol/L in 2-fold serial dilutions at a flow rate of 20 μL/min. Triplicate injections of each MO concentration were analyzed. The MO-HSA complex was allowed to associate for 3 min and the surface was washed with running buffer for 3 min. Binding was analyzed by performing a steady-state affinity analysis by using the BIAevaluation program. After completion of the assay procedure, the surface was regenerated using 50 mmol/L NaOH (5, 10, 15) .
RESULTS AND DISCUSSION
When MO binds to HSA in an aqueous solution, the solution undergoes a color change that is similar to the change in its pH. MO (Fig. 1A) and MO • H + (Fig. 1B) are the main structures in basic (> pH 3.8, pKa of MO) and acidic (< pH 3.8) solutions, respectively. The mutual structural transformation of both ions (A to B and B to A in Fig. 1 ) is accompanied by a visible color change that occurs with the transfer of a proton from water to MO or vice versa. A compound containing a sulfo group is a strong acid, and therefore MO dissociates at all the pH ranges analyzed. MO • H + , which possesses resonance structures, absorbs light of longer wavelength (λ max = 503 nm) than does MO (λ max = 465 nm). Determining the amounts of MO • H + and MO accurately using a photometric method at these wavelengths is difficult because of their overlap. Thus, 427 and 560 nm were the wavelengths employed for determining the amount of MO and MO • H + , respectively; these wavelengths exhibit little mutual interference. The absorbance at 427 nm increased and that at 560 nm decreased depending on the HSA concentration in a solution of pH 3.0 (Fig. 2) . Because the color change occurred in a buffer solution of constant pH, a proton exchange clearly occurred between MO and HSA. The color change of an MO-HSA complex is caused by a proton-exchange reaction. The change in the absorbance of the MO-HSA complex dependcan be attributed to a proton exchange between BCP and an acidic group or a basic group of HSA (8) . Considering the similarity of pH indicators with respect to their pH-dependent color change, the colorchanging mechanism of a methyl orange (MO)-HSA complex should be the same as that of a BCP-HSA complex. Therefore, this study analyzed the colorchange mechanism by using the same method used in our previous study (8) . Additional experiments were performed to ascertain the features of the MO-HSA interaction and the structure of the MO-binding site on HSA. Various ligands such as fatty acids and drugs bind to the specific binding sites present on an HSA molecule, which is a major transport protein in plasma (2) . The precise structures of the binding sites have been studied by performing crystallographic analyses of the complexes (6). However, little information has been obtained regarding the binding sites of the pH indicators. Therefore, we evaluated the features of an MO-binding site containing the critical residues for color change based on crystallographic data (12) .
MATERIALS AND METHODS

Materials.
Reagents for buffer preparation, warfarin, ibuprofen, and MO were purchased from WAKO Chemical Co. (Osaka, Japan). Fatty acid-free HSA and dimethyl sulfoxide (DMSO) were purchased from Sigma-Aldrich Japan (Tokyo, Japan). The maximum amount of MO • H + formed is proportional to the amount of MO or the carboxyl group. The amount of MO • H + at a particular pH is calculated using the Henderson-Hasselbalch equa-HSA molecule showed the same pattern as that of drug-HSA complexes (13) . However, all of the bound MO molecules do not participate in the color change. MO binds to HSA through an electrostatic interaction between a dissociated sulfo group (SO 3 − ) and a protonated basic group on HSA. However, neutralization of the electric charges by an electrostatic interaction between a dissociated acidic group and a protonated basic group inhibits the binding of an MO molecule to the basic group. The ionization of the carboxyl group is suppressed at reduced pH. Consequently, MO • SO 3 − could bind to the released protonated amino group. Methyl red (MR) and methyl yellow (MY), which are diazo pH indicators, showed little binding to the SPR-based sensor (Fig. 4) . ing on the pH (2.4-6.6) was measured at 560 nm (Fig. 3) . The calculation of the pH-dependent formation of MO • H + revealed a similarity between the experimental and calculated plots in this pH range (Fig. 3) . The best-fit pKa values for MO and a carboxyl group of HSA were 3.8 and 1.4, respectively. This result validates the color-change mechanism described in METHODS, and demonstrates a crucial role of a carboxyl group of HSA. This pKa value is lower than that for α, β, or γ carboxyl groups. The low value would be caused by an interaction between an acidic group and an adjacent group. HSA possesses 99 acidic and 97 basic residues. The dissociation of an acidic group adjacent to a basic group would be promoted by electrostatic interactions between the groups. The dissociation of such an acidic group would be accelerated and thus the pKa value will be lowered; pKa values are known to increase or decrease in the presence of favorable interactions (hydrogen bonding, electrostatic interactions, and hydrophobic interactions) between amino acid residues of proteins (11) . The binding of MO to HSA is the first stage of the color-change mechanism of the MO-HSA complex. The most suitable method for confirming the binding is an analysis performed using an SPR biosensor, which is an established method for verifying molecular interactions (5, 10, 15) . The binding ratio of MO molecules to a single HSA molecule was analyzed by means of SPR analysis. The ratio was 1-2 at pH 3.6-7.2 and approximately 4 at pH 2.4. The result shows that 1 or 2 MO molecules bind to an HSA molecule at pH 3.6-7.2 and 4 MOs bind at pH 2.4 (Fig. 4) . The sensorgram of MO binding to an electrostatic interaction between MO • SO 3 − and Arg218/Lys444 sidechains, between each N atom in the MO diazenyl group and Lys195/Glu292 sidechains, and between the N atom in the MO dimethylamino group and the Lys199 sidechain. Furthermore, hydrophobic interaction occurred between the MO dimethylamino group and the Tyr150 phenyl ring and between the MO phenyl ring and the Ala291
Preparation of buffers.
Because MR and MY contain no sulfo group (Fig. 1C  and 1D ), the sulfo group of MO plays a critical role in the binding. HSA is a 66-kDa monomeric protein that contains 3 homologous helical domains, I-III, each of which is divided into 2 subdomains, A and B. Two drugbinding sites located in subdomains IIA and IIIA (drug-binding sites 1 and 2) have been identified on the HSA molecule (4, 6, 12) . BCP is considered to bind to HSA through these 2 drug-binding sites: site 1, which is bound by warfarin, an anticoagulation drug; and site 2, which is bound by ibuprofen, a nonsteroidal anti-inflammatory drug (9) . Therefore, we sought to determine whether an MO molecule also binds to these sites by conducting an inhibition experiment. The absorbance of the MO-HSA complex was measured in the presence of warfarin or ibuprofen. The absorbance was decreased-relative to control (no drugs)-by 10% when warfarin was included, but was increased by 5% when ibuprofen was present (Fig. 5) . This result demonstrates that MO binds to a warfarin-binding site of HSA and not to an ibuprofen-binding site. The structure of an MO-HSA complex was analyzed using Molecular Operating Environment (MOE: Chemical Computing Group Inc., Montreal, Quebec, Canada; http:/www.chemcomp.com/), based on the data of the warfarin-HSA complex (PDB data: 2BXD) (12). MO and MO • H + both appeared to bind to the entrance of the warfarin hole in HSA, and thus they might be able to prevent the binding of warfarin to HSA (Fig. 6A) . The predicted MO structure could be fixed by hydrogen bonding and sidechain. The carboxyl group of Glu292 could readily protonate the diazenyl group of MO because of the positional relationship of these groups and the hydrogen bond between Glu292 and Lys195. The 2 resonance structures of MO • H + (Fig. 1B) in HSA also appeared to be retained in the entrance of the warfarin hole (Fig. 6B and 6C) . One of these structures was positively charged in the diazenyl group (Fig. 6B) , and its positive charge caused the tight interaction with Glu292 and the loss of the hydrogen bond with Lys195. The N atom in the dimethylamino group in the other structure forms a hydrogen bond with Glu153 instead of with Lys199 (Fig. 6C) . In these structures, SO 3 − and the dimethylamino groups of MO • H + were fixed in the same manner in the aforementioned predicted structure of the MO-HSA complex (Fig. 6A) . The hydrogen bond between the Glu292 and Lys195 sidechains was also maintained in all stages. In these molecular interactions, we postulate that interactions of MO with Glu292 and Lys195 might be directly related to MO protonation and the following color change. Furthermore, interactions with hydrogen-bond-donor residues (Lys195/Lys199) and hydrogen-bond-acceptor residues (Glu292/Glu153) would be crucial for the binding of MO and MO • H + , respectively. These structural findings appear to correspond with the experimental results presented above.
In conclusion, the color-change mechanism of the MO-HSA complex is presumed to be the following: an MO molecule binds to the warfarin-binding site of an HSA molecule by means of electrostatic interaction between MO • SO 3 − and protonated ε-amino (Lys444) and guanidino (Arg218) groups. Subsequently, a color change occurs as a result of a proton exchange between the diazenyl group and the γ-carboxyl group of Glu292. This color-change mechanism was elucidated here based on the results of pH-dependency experiments and calculations performed using the Henderson-Hasselbalch equation. The dissociation of the carboxyl group is suppressed by an electrostatic interaction with the protonated ε-amino group of Lys195. Color-changed MO is fixed to the warfarin site of HSA through additional interactions: electrostatic interaction (MO • SO 3 − and Lys144/Arg218 sidechains), hydrogen bonding, and hydrophobic interaction (MO • N + (CH 3 ) 2 and Glu153 sidechain, MO and Ala291/Tyr150 sidechains). This study helps elucidate the MO-HSA colorchange mechanism and the structure of the binding site on an HSA molecule, and thus the findings can support the development of a dye-binding method that enables accurate measurements, and of a novel 6 Possible modes of binding of MO to the warfarinbinding site on HSA. In (A), the predicted structure of MO bound to the warfarin-binding site of HSA is shown in orange together with the molecular surface. The MO structure was observed to be rigidly fixed to the entrance of the warfarin hole in the X-ray structure of the HSA complex (PDB; 2BXD) and was optimized without warfarin in the binding site by means of energy minimization. The molecular surface of warfarin in the HSA structure is superimposed in light blue. The 2 predicted resonance structures of protonated MO (MO • H + ) in the same site of HSA are shown in (B) and (C). These structures were also optimized through energy minimization. In all figures, molecular models are described without hydrogen atoms, except for the hydrogen atom (shown in green) moved from protonated Glu292 (A) to MO (B and C), and the residues surrounding HSA and the surface accessible to the solvent are described using line or ball-stick drawing and light-gray translucent objects. Nitrogen, oxygen and sulfur atoms are shown in blue, red, and yellow, respectively, and hydrogen-bond distances are shown in dark violet. All molecular-modeling operations, including ligand fitting, energy minimization, and molecular drawing, were performed using the modeling package MOE (Chemical Computing Group, Inc., http://www.chemcomp.com/). Energy minimization was performed using Amber12:EHT force field implemented in MOE for protein-ligand interactions.
tissue-staining method involving the use of a newly synthesized dye.
